Using scRNA-seq in combination with genetic variation analysis, Wang et al. (Wang et al. 2022) elucidate that MYC amplification and RB1 deletion can induce PCa, and NEPC might originate from KLK3-negative and untreated adenocarcinoma cells. The gene discussed is MYC; the disease is adenocarcinoma.